Knaus Maria E, Onwuka Amanda J, Abouelseoud Naila M, Bergus Katherine C, Breech Lesley L, Brito Katherine S, Dekonenko Charlene, Hertweck S Paige, Hong Helena Y, Menon Seema, Merritt Diane F, Schikler Allegra G, Senapati Nikki, Smith Yolanda R, Strickland Julie L, Truehart Amber I, Minneci Peter C, Hewitt Geri D
Center for Surgical Outcomes Research, Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, Ohio; Division of Pediatric Surgery, Department of Surgery, The Ohio State University College of Medicine, Nationwide Children's Hospital, Columbus, Ohio.
Center for Surgical Outcomes Research, Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, Ohio.
J Pediatr Adolesc Gynecol. 2023 Apr;36(2):160-166. doi: 10.1016/j.jpag.2022.11.006. Epub 2022 Dec 8.
To examine the recurrence rates of pediatric benign ovarian neoplasms METHODS: A retrospective review of females up to 21 years of age who underwent surgery for a benign ovarian neoplasm at 8 pediatric hospitals from January 2010 through December 2016 was conducted. Data include primary operation details, follow-up imaging, and reoperation details.
Four hundred and twenty-six females were included in our cohort, with a median age of 15 years at the time of the primary operation. Of the patients, 69% had a mature teratoma, 18% had a serous cystadenoma, and 8% had a mucinous cystadenoma. Two-thirds of patients underwent ovarian-sparing surgery. There were 11 pathologically confirmed recurrences (2.6%) at a median follow-up of 12.8 months. The pathologically confirmed recurrence was 10.5 per 100 person-months at 12 months (SE = 5.7) for mucinous cystadenomas and 0.4 months (SE = 0.4) for mature teratomas (P = .001). For half of the patients, the pathologically confirmed recurrences occurred by 12.8 months, and for 75%, they occurred by 23.3 months. There were no differences in reoperation or recurrence on the basis of initial procedure (ovary-sparing surgery vs oophorectomy).
We measured the pathologically confirmed recurrence rate for pediatric benign ovarian neoplasms in a large cohort. Oophorectomy was not protective against recurrence. Mucinous cystadenomas were at a greater risk of pathologically confirmed recurrence.
探讨小儿良性卵巢肿瘤的复发率。
对2010年1月至2016年12月期间在8家儿科医院接受良性卵巢肿瘤手术的21岁及以下女性进行回顾性研究。数据包括初次手术细节、随访影像学检查和再次手术细节。
我们的队列纳入了426名女性,初次手术时的中位年龄为15岁。其中,69%患有成熟畸胎瘤,18%患有浆液性囊腺瘤,8%患有黏液性囊腺瘤。三分之二的患者接受了保留卵巢手术。在中位随访12.8个月时,有11例经病理证实复发(2.6%)。黏液性囊腺瘤在12个月时经病理证实的复发率为每100人月10.5次(标准误=5.7),成熟畸胎瘤为每100人月0.4次(标准误=0.4)(P=0.001)。一半的患者在12.8个月时出现经病理证实的复发,75%的患者在23.3个月时出现复发。根据初始手术方式(保留卵巢手术与卵巢切除术),再次手术或复发情况没有差异。
我们在一个大型队列中测量了小儿良性卵巢肿瘤经病理证实的复发率。卵巢切除术并不能预防复发。黏液性囊腺瘤经病理证实的复发风险更高。